Eurointervention

Article	Citations
Supporting evidence for ST-segment elevation myocardial infarction from optical coherence tomography	216
Letter: ORBITA-2 trial design and rationale: what causes angina after PCI?	107
Intracoronary polarimetry of a honeycomb-like structure	87
Thirty years of transradial coronary interventions	87
In search of the “IDEAL” left main coronary stent and DAPT regimen	78
Deep learning for prediction of fractional flow reserve from resting coronary pressure curves	73
Long-term outcomes of measured and predicted prosthesis-patient mismatch following transcatheter aortic valve replacement	70
Women and coronary artery disease: not just underrepresented and underdiagnosed, but also undertreated!	63
Impella – a treatment for all STEMI patients with cardiogenic shock? The effect of off-hours admission	58
Robotic-assisted percutaneous coronary intervention: the future or the past?	57
Real-world evidence with the ACURATE neo2: a prelude to the ACURATE IDE trial	54
Reply: Due to the lack of significant mortality benefits along with high procedural complication rates, percutaneous coronary intervention of chronic total occlusions should be discouraged	52
Double-tap to treat paravalvular leak in high-risk annuli	50
Diagnostic accuracy of quantitative flow ratio in patients with arrhythmias	48
The patent foramen ovale does not spontaneously close in patients aged 60	46
Reply: Identifying vulnerable coronary atherosclerotic plaques: from theory to practice	45
Safety and efficiency of percutaneous coronary intervention using a standardised optical coherence tomography workflow	42
A double-blind randomised placebo-controlled trial of percutaneous coronary intervention for the relief of stable angina without antianginal medications: design and rationale of the ORBITA-2 trial	41
ACURATE neo2: jack of all trades or master of none?	41
Mechanical thrombectomy for pulmonary embolism revisited: technological breakthrough or simple renovation?	39
The conundrum of percutaneous coronary intervention without aspirin: a call for clarity	39
Clinical impact of intervention strategies after failed transcatheter mitral valve repair	39
Management of a giant dual-chamber pseudoaneurysm of the proximal left anterior descending artery	38
Targeting inflammation in atherosclerosis: overview, strategy and directions	38
In search of the origin of the acronym TAVI	37

Transcatheter heart valve thrombosis on the mitral stage: “The Tempest” or “Much Ado About Nothing”?	36
The POT-PUFF sign: an angiographic mark of stent malapposition during proximal optimisation	35
Transcatheter left ventriculoplasty	35
Outcomes of directional atherectomy for common femoral artery disease	34
Phasic flow patterns of right versus left coronary arteries in patients undergoing clinical physiological assessment	32
Reply: When is the optimal time point for detecting malapposition in coronary bifurcation trials?	31
Should we routinely use ultrasound-guided transfemoral access for coronary procedures? High-quality evidence from an individual participant data meta-analysis	30
Transcatheter tricuspid interventions are performed too late: pros and cons	28
Reviewing scientific manuscripts in 2023: is it (still) worth the time?	26
First-in-human description of a novel transcatheter tricuspid valve prosthesis to preserve the asymmetric shape of the right ventricle	26
TAVR under 70: is age just a number?	26
Fatal acute mesenteric ischaemia following transcatheter aortic valve replacement	25
Outcomes of valve-in-valve transcatheter aortic valve implantation with and without bioprosthetic valve fracture	25
Breaking down the barriers in the management of INOCA: how can we do better in the diagnosis of coronary vasomotor disorders?	25
Pressure-bounded coronary flow reserve to assess the extent of microvascular dysfunction in patients with ST-elevation acute myocardial infarction	25
Letter: Pretreatment with unfractioned heparin in patients undergoing primary PCI: a standard of treatment together with DAPT?	25
Clinical outcomes of no stenting in patients with ST-segment elevation myocardial infarction undergoing deferred primary percutaneous coronary intervention	24
Reconsidering the evidence for CTO PCI: the devil is in the detail	24
Prevalence and patterns of in-stent neoatherosclerosis in lower extremity artery disease	24
Transcatheter aortic valve implantation: the shape matters	23
Predictors of non-stenting strategy for acute coronary syndrome caused by plaque erosion: four-year outcomes of the EROSION study	22
Computer-based prediction of coronary artery compression in the planning of transcatheter pulmonary valve implantation	22
Predictors and outcomes of neoatherosclerosis in patients with in-stent restenosis	22
Reply: Composite endpoints in clinical trials - simplicity or perfection?	22
Transapical transcatheter mitral valve implantation in patients with prior aortic valve replacement: a feasibility report	22
Radial wall strain: a novel angiographic measure of plaque composition and vulnerability	21
International variation in modality and outcomes of left main revascularisation: does it really matter?	21
Safety of early hospital discharge following admission with ST-elevation myocardial infarction treated with percutaneous coronary intervention: a nationwide cohort study	21
Temporal trends in characteristics of patients undergoing transcatheter tricuspid edge-to-edge repair for tricuspid regurgitation	21
Three-year outcomes of transcatheter aortic valve implantation for bicuspid versus tricuspid aortic stenosis	21
Predictors and clinical impact of worsening left ventricular ejection fraction after mitral transcatheter edge-to-edge repair	21
Recanalisation of coronary chronic total occlusions	20
Near-infrared spectroscopy to predict plaque progression in plaque-free artery regions	20
Impact of moderate or severe left ventricular outflow tract calcification on clinical outcomes of patients with severe aortic stenosis undergoing transcatheter aortic valve implantation with self- and	19
Principles and pitfalls in coronary vasomotor function testing	18
Development and validation of a scoring system for predicting clinical coronary artery perforation during percutaneous coronary intervention of chronic total occlusions: the PROGRESS-CTO perforation s	18
Membranous septum morphology and risk of conduction abnormalities after transcatheter aortic valve implantation	18
How to set up regional STEMI networks: a "Stent - Save a life!" initiative	17
Intravascular ultrasound guidance for lower extremity arterial and venous interventions	17
Prognostic value of structural and functional coronary microvascular dysfunction in patients with non-obstructive coronary artery disease; from the multicentre international ILIAS registry	17
Super high-pressure balloon versus scoring balloon to prepare severely calcified coronary lesions: the ISAR-CALC randomised trial	16
Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantation	16
A staging classification of right heart remodelling for patients undergoing transcatheter edge-to-edge mitral valve repair	16
Valve-in-valve transcatheter aortic valve implantation versus repeat surgical aortic valve replacement in patients with a failed aortic bioprosthesis	16
Comprehensive diagnosis in chronic coronary syndromes combining angiography and intracoronary testing: the AID-ANGIO study	15
Outcomes by sex in the International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA) trial	15
Impact of right ventricular-pulmonary arterial coupling on clinical outcomes of tricuspid regurgitation	15
Applied coronary physiology for planning and guidance of percutaneous coronary interventions. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions	15
Venoarterial extracorporeal membrane oxygenation or standard care in patients with cardiogenic shock complicating acute myocardial infarction: the multicentre, randomised EURO SHOCK trial	15
Echocardiographic guidance in transcatheter structural cardiac interventions	14

A direct wire pacing device for transcatheter heart valve and coronary interventions: a first-in-human, multicentre study of the Electroducer Sleeve	14
Left atrial appendage closure for thrombus trapping: the international, multicentre TRAPEUR registry	14
Incidence and mechanisms of bioprosthetic dysfunction after transcatheter implantation of a mechanically-expandable heart valve	14
Transcatheter valve repair in congenitally corrected transposition of the great arteries	14
Reply: Pretreatment with unfractionated heparin in patients undergoing primary PCI: a standard of treatment together with DAPT?	13
A study of the novel SinoCrown system for transcatheter aortic valve implantation	13
Polymer-free versus biodegradable-polymer drug-eluting stent in patients undergoing percutaneous coronary intervention: an assessor-blind, non-inferiority, randomised controlled trial	13
Bioprosthetic valve fracture: haemodynamically effective but safe and clinically necessary?	13
STEMI outcomes in the era of COVID-19: reaffirmation of an unfortunate reality	13
High-risk percutaneous coronary intervention in patients with reduced left ventricular ejection fraction deemed not suitable for surgical revascularisation. A clinical consensus statement from the Eur	13
Twelve-month outcomes of the LuX-Valve for transcatheter treatment of severe tricuspid regurgitation	13
Direct oral anticoagulants for ventricular thrombus resolution: pilot trials show reassuring efficacy and safety compared to warfarin	13
Managing the device-related risk of in-stent restenosis and stent thrombosis in coronary stenting	13
Bicuspid is different	12
Stent underexpansion in the CRUNCH registry: worth cracking?	12
TAVI in moderate aortic stenosis and heart failure: pros and cons	12
Do we need another device for catheter interventional closure of septum secundum atrial septal defects?	12
Percutaneous tricuspid valve annuloplasty: additional data and remaining questions	12
Redo-TAVI with a balloon-expandable valve and the impact of index transcatheter aortic valve design	12
Standardisation of techniques for bifurcation stenting optimisation: the journey continues	12
Catheter directed therapies: an option for elderly frail patients with pulmonary embolism requiring reperfusion	12
Valve-in-valve TAVI: the new standard therapy for failing bioprosthetic valves?	12
Anterior mitral leaflet modification with endoscopic scissors during Tendyne implantation	12
To be better among the best: a difficult task	11
Redo-TAVI feasibility and coronary accessibility following index TAVI with the Evolut valve in patients with bicuspid aortic valve stenosis	11
Low-dose fibrinolysis during primary percutaneous intervention for preventing no-reflow: stepping back to move forward?	11
Durability of transcatheter aortic valve implantation in bicuspid aortic valve stenosis: the last missing piece?	11
Transseptal puncture in patients with septal occluder devices during catheter ablation of atrial fibrillation	11
Some endotypes of microvascular dysfunction may be more worrisome than others	11
Heparin pretreatment in STEMI: is earlier always better?	11
The “road travelled”: reflections on the transformation of information exchange in a digital age	10
Defer-based non-stenting: a promising approach for STEMI	10
Microaxial flow pump for high-risk PCI: are we ready for the prime time?	10
Timing and predictors of definite stent thrombosis in comatose survivors of out-of-hospital cardiac arrest undergoing percutaneous coronary intervention and therapeutic hypothermia (ST-OHCA study)	10
Reply: Caffeine and fractional flow reserve overestimation: a word of caution	10
Reply: ORBITA-2 trial design and rationale: what causes angina after PCI?	9
Rotational atherectomy combined with cutting balloon to optimise stent expansion in calcified lesions: the ROTA-CUT randomised trial	9
Transcatheter edge-to-edge repair with the PASCAL device for failed MitraClip procedure	9
A bench study of balloon-expandable valves for the treatment of self-expanding valve failure	9
PCI of bystander coronary artery lesions should be performed before TAVI: pros and cons	9
Transcatheter edge-to-edge valve repair versus minimally invasive beating-heart surgery of the tricuspid valve: an observational study	9
Selective intracoronary hypothermia in patients with ST-elevation myocardial infarction. Rationale and design of the EURO-ICE trial	8
Ten-year clinical outcomes of drug-eluting stents with different polymer coating strategies by degree of coronary calcification: a pooled analysis of the ISAR-TEST 4 and 5 randomised trials	8
Clinical outcomes of transcatheter mitral valve replacement: two-year results of the CHOICE-MI Registry	8
Temporal trends in clinical outcomes after percutaneous coronary intervention: a systematic review of 66,327 patients from 25 all-comers trials	8
Mortality after bleeding versus myocardial infarction in coronary artery disease: a systematic review and meta-analysis	8
Histological examination of renal nerve distribution, density, and function in humans	8
Transcatheter edge-to-edge mitral valve repair in patients with mitral annulus calcification	8
Transcatheter edge-to-edge repair of severe calcific mitral regurgitation facilitated by balloon lithotripsy	8
Outcomes of excimer laser-contrast angioplasty for stent underexpansion	7
One-year outcomes after transcatheter aortic valve implantation with the latest-generation SAPIEN balloon-expandable valve: the S3U registry	7
Transseptal puncture: procedural guidance, challenging situations and management of complications	7
Long-term safety of drug-coated devices for peripheral revascularisation	7
Drug-coated stents versus bare metal stents in Academic Research Consortium-defined high bleeding risk patients	7
Long-term changes in coronary physiology after aortic valve replacement	7
Thermodilution-derived temperature recovery time: a novel predictor of microvascular reperfusion and prognosis after myocardial infarction	7
Observational studies play little role in guiding evidence-based medicine: pros and cons	6
Haemodynamic performance and clinical outcomes of transcatheter aortic valve replacement with the self-expanding ACURATE neo2	6
   Atrial fibrillation and acute coronary syndrome 	6
Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients at low to intermediate surgical risk: rationale and design of the randomised DEDICATE Trial	6
Defining high bleeding risk in patients undergoing transcatheter aortic valve implantation: a VARC-HBR consensus document	6
Hybrid coronary revascularisation: the best or the worst of both worlds?	6
Can machine learned algorithms further illuminate intracoronary imaging in PCI and improve the human touch?	6
Long-term outcomes of catheter-based intervention for clinically significant paravalvular leak	6
One-month DAPT after acute coronary syndrome: too short or not too short?	6
Impact of chronic kidney disease and diabetes on clinical outcomes in women undergoing PCI	6
TAVI at 20: how a crazy idea led to a clinical revolution	6
Safety and performance of a novel cerebral embolic protection device for transcatheter aortic valve implantation: the PROTEMBO C Trial	6
Predictors of late lumen enlargement after drug-coated balloon angioplasty for de novo coronary lesions	6
Artificial intelligence and optical coherence tomography for the automatic characterisation of human atherosclerotic plaques	6
SAPIEN 3 Ultra: better sealing, reduced paravalvular leak and a move in the right direction?	6
Economic evaluation of fractional flow reserve-guided versus angiography-guided multivessel revascularisation in ST-segment elevation myocardial infarction patients in the FLOWER-MI randomised trial	5
Single antiplatelet therapy directly after percutaneous coronary intervention in non-ST-segment elevation acute coronary syndrome patients: the OPTICA study	5
Life expectancy of patients with a transcatheter aortic valve and the implications for long-term valve durability data collection	5
A multicentre, prospective, randomised controlled trial to assess the safety and effectiveness of cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarc	5
Twelve-month outcomes of the TaurusOne valve for transcatheter aortic valve implantation in patients with severe aortic stenosis	5
Predictors and prognostic relevance of tricuspid alterations in patients undergoing transcatheter edge-to-edge mitral valve repair	5
Geographical variations in left main coronary artery revascularisation: a prespecified analysis of the EXCEL trial	4
Letter: Spontaneous coronary artery dissection in France	4
EuroIntervention: the 200th issue	4

Reply: Spontaneous coronary artery dissection in France	4
ARC-HBR criteria and TAVR: not all high bleeding risk patients look alike	4
Treatment of coronary bifurcation lesions, part II: implanting two stents. The 16th expert consensus document of the European Bifurcation Club	4
Paravalvular regurgitation after TAVI: the forgotten enemy	4
New European insights on spontaneous coronary artery dissection (SCAD): are we any closer in our scientific exploration voyage?	4
Combined functional and anatomical assessment of coronary stenosis by coronary CT angiography	4
Antithrombotic therapy after percutaneous coronary intervention of bifurcation lesions	4
Mitral regurgitation improvement after TAVI: if well planned, two birds are killed with one stone	4
Patient-prosthesis mismatch following TAVR: time will tell	4
TAVI in younger patients with bicuspid aortic stenosis: pros and cons	4
Bioabsorbable coronary stents - should they be buried?	4
Scores and algorithms in CTO PCI: “PROGRESS” or an exercise in futility?	4
Automated analysis of coronary angiograms using artificial intelligence: a window into the cath lab of the future	4
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation	4
Transcatheter aortic valve implantation with the Evolut platform for bicuspid aortic valve stenosis: the international, multicentre, prospective BIVOLUTX registry	4
Walking the tightrope between ischaemia and bleeding	4
Severely calcified coronary stenoses: a war or a battle?	4
Direct wire pacing for transcatheter mitral valve replacement	4
Stratifying cardiovascular risk in patients with microvascular dysfunction: new insights from emerging physiology metrics	4
Learning the lessons (again) of the challenges of conducting sham-controlled device trials in hypertension	4
Letter: Caffeine and fractional flow reserve overestimation: a word of caution	4
Performance and outcomes of the SAPIEN 3 Ultra RESILIA transcatheter heart valve in the OCEAN-TAVI registry	4
EAPCI Presidential “criss-cross”	4
Improved diagnostic indices for coronary microvascular impairment in ST-elevation myocardial infarction; we’ve just begun, and now it’s time to use them to improve outcomes	4
Redo transcatheter mitral valve replacement in mitral annular calcification	4
PCR London Valves - in person or online - an invaluable opportunity for exchange dedicated to advancing the treatment of valvular heart disease	4
Percutaneous coronary interventions for ostial left main disease: the future is bright.	3
Coronary access techniques following ACURATE neo2 implantation in surgical bioprosthesis	3
Embolisation of a prosthetic mitral valve fragment during valve-in-valve transcatheter mitral valve implantation	3
Comparison of acute thrombogenicity and albumin adsorption in three different durable polymer coronary drug-eluting stents	3
Long-term clinical outcomes of percutaneous coronary intervention for ostial left main coronary artery disease	3
Removing roadblocks in pulmonary circulation: centres of excellence and interhospital networks	3
Transcatheter aortic valve implantation in degenerated surgical aortic valves	3
Double LAmbre technique for percutaneous occlusion of very large left atrial appendages: a case series	3
Brachial arterial access for PCI: an analysis of the British Cardiovascular Intervention Society database	3
Picture perfect? Performance of quantitative coronary angiography-based vessel FFR versus pressure wire-based FFR	3
Transoesophageal echocardiography guidance with paediatric probes in adults undergoing left atrial appendage occlusion	3
A sham-controlled randomised trial of pulmonary artery denervation for Group 1 pulmonary arterial hypertension: one-year outcomes of the PADN-CFDA trial	3
Periprocedural continuation versus interruption of oral anticoagulant drugs during transcatheter aortic valve implantation: rationale and design of the POPular PAUSE TAVI trial	3
High bleeding risk patients: one size does not fit all	3
Procedural considerations for transcatheter aortic valve-in-valve implantation in a degenerated ACURATE neo prosthesis	2
Impact of off-hours admissions in STEMI-related cardiogenic shock managed with microaxial flow pump – insights from J-PVAD	2
New-onset or newly detected atrial fibrillation after transcatheter aortic valve implantation?	2
Outcomes of newly diagnosed atrial fibrillation in patients with acute coronary syndromes	2
Low-flow, low-gradient aortic stenosis: an understanding is still a long way off	2
Left atrial appendage angiography for stroke risk prediction in patients with atrial fibrillation	2
Early outcomes of transcatheter versus surgical aortic valve implantation in patients with bicuspid aortic valve stenosis	2
Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: a multicentre registry	2
Long-term clinical outcomes of robotic-assisted surgical coronary artery revascularisation	2
Napkin ring formation in culotte stenting using current-generation drug-eluting stents in left main coronary artery bifurcation	2
                Late lumen enlargement after drug-coated balloo	2
BioMatrix versus Orsiro biodegradable polymer stents in all-comer patients with coronary artery disease: the multicentre, randomised BIODEGRADE trial	2
Mitral valve transcatheter edge-to-edge repair	2
Direct oral anticoagulants or warfarin in patients with left ventricular thrombus after ST-elevation myocardial infarction: a pilot trial and a prespecified meta-analysis of randomised trials	2
Sirolimus-eluting stents with ultrathin struts versus everolimus-eluting stents for patients undergoing percutaneous coronary intervention: final three-year results of the TALENT trial	2
Ultrasound-guided femoral access in patients with vascular closure devices: a prespecified analysis of the randomised UNIVERSAL trial	2
Transcatheter interventions for left-sided valvular heart disease complicated by cardiogenic shock: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EA	2
Outcomes and performance of the ACURATE neo2 transcatheter heart valve in clinical practice: one-yearresults of the ACURATE neo2 PMCF Study	2
Recyclable and contaminated waste from cardiac procedures: a call to action for a sustainable catheterisation laboratory and operating theatre	2
Invasive functional testing in the cath lab as a routine investigation in INOCA: pros and cons	2
We now have enough evidence to support systematic OCT in daily PCI practice: pros and cons	2
A novel robotic radiation shielding device for interventional cardiology procedures	2
What makes a plaque rupture? A simple answer seems too much to ask for	2
Bringing order to chaos. Invasive functional assessment for all patients in the cath lab?	2
Long-term survival after TAVI in low-flow, low-gradient aortic valve stenosis	2